Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-21

Clinical Trial Update: Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy results for bimosiamose cream in treating psoriasis have been completed, evaluating its potential to improve psoriasis symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimosiamose Cream (bimosiamose)

Snippet

Sponsor: Revotar Biopharmaceuticals AG | Conditions: Psoriasis | Phase 2 | Status: COMPLETED